Efbemalenograstim alfa Disease Interactions
There is 1 disease interaction with efbemalenograstim alfa.
Moderate
Efbemalenograstim alfa-vuxw (applies to efbemalenograstim alfa) sickle cell disorders
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Sickle Cell Anemia
Efbemalenograstim alfa-vuxw may cause severe and potentially fatal sickle cell crisis in patients with sickle cell disorders. If sickle cell crisis occurs, discontinue Efbemalenograstim alfa-vuxw.
References
- (2023) "Product Information. Ryzneuta (efbemalenograstim alfa)." Evive Biotech
Efbemalenograstim alfa drug interactions
There are 172 drug interactions with efbemalenograstim alfa.
More about efbemalenograstim alfa
- efbemalenograstim alfa consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: colony stimulating factors
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.